About this trial
The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments?
Researchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery.
Participants will:
* Receive ERAS protocol during the hospitalization * Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7 * Visit the hospital at one week and one month after discharge * Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 20 and 70 years
Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia
Use of an Android smartphone
Disqualifiers
American Society of Anesthesiologists(ASA) physical status classification IV or higher
Body Mass Index (BMI) 35 or higher
Presence of diabetic autonomic neuropathy
History of esophageal hiatal hernia or delayed stomach discharge
Trial design
Parallel
Treatments tested in this trial
Enhanced Recovery After Surgery
Procedure/Surgery1. Before surgery * Sips of water until 6 AM on the day of surgery, followed by a 200 mL carbohydrate drink * Pre-emptive oral analgesics (celecoxib 200mg 1 cap + acetaminophen 650mg 2 tab) 2. During surgery * Total intravenous anesthesia * Local anesthetic infiltration at the laparoscopic port site for post-operative pain control 3. After surgery * Sips of water and a foley catheter removal on ward arrival * Soft meal 4 housr after surgery * General diet 8 hours after surgery
Usual Care
Procedure/Surgery1. Before surgery * Midnight NPO * No pre-emptive analgesics 2. During surgery * Balanced anesthesia 3. After surgery * Sips of water 8 hours after arrival in the ward * Foley catheter removal one day after the surgery * Soft meal after gas out * General diet after one soft meal
Treatment groups
Trial outcomes
Primary outcomes
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
Quality of Recovey-15, Korean version (QoR-15K)
This patient-reported outcome measure consists of 15 items. Each item is rated on an 11-point Likert scale (0-10), yielding a total score ranging from 0 (very poor recovery) to 150 (excellent recovery). Higher scores indicate a better postoperative recovery.
The World Health Organization Disability Assessment Schedule, 2nd Edition (WHODAS 2.0)
WHODAS 2.0 questionnaire consists of 36 items rated on a 5-point Likert scale (1-5), yielding a total score ranging from 36 to 180. Higher scores represent greater disability and poorer functioning.
Secondary outcomes
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Pain (Visual analogue scale)
The Visual Analogue Scale (VAS) for pain ranges from 0 to 100, where 0 represents no pain and 100 represents the worst imaginable pain. Higher scores indicate more severe pain.
Length of stay
Other outcomes
Heart rate variability
measured from wearable electrocardiography and a smart watch
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Wonju Severance Christian Hospital
Lead sponsor
Ministry of Trade, Industry & Energy, Republic of Korea
Collaborator
This trial is not recruiting at the moment. You can still explore other options: